Premier Diagnostic Health Services Inc. Announces New Board and Officer Appointments

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 9, 2014) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA.

Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH) is pleased to announce that the election of three new members to its board of directors and the appointment of new officers.

Premier's New Board Members are:

SIMON SUTCLIFFE, M.D., FRCP, FRCP(C), FRCR

A distinguished clinician and scientist, Dr. Simon Sutcliffe joined Premier's board as of June 1, 2014. He is well regarded as a leader in cancer control. A graduate of St. Bartholomew's Hospital, London, England in 1970, Dr. Sutcliffe's training encompassed internal medicine, scientific research, medical and radiation oncology in the UK, South Africa, US and Canada. Dr. Sutcliffe has held staff appointments at St. Bartholomew's Hospital, Princess Margaret Hospital/Ontario Cancer Institute and the BC Cancer Agency.

Dr. Sutcliffe is past President and CEO of the BC Cancer Agency (2000-2009), and prior to that, he was President and CEO of Ontario Cancer Institute/Princess Margaret Hospital (1994-1996). He chairs the Board of the Institute for Health Systems Transformation and Sustainability; is President of the International Cancer Control Congress Association, the International Network for Cancer Treatment and Research-Canada Branch (Two Worlds Cancer Collaboration); is a Senior Advisor to the Terry Fox Research Institute and is Chief Medical Officer for QuBiologics Inc. and Omnitura Inc. He is a past Chair of the Board of the Canadian Partnership Against Cancer (CPAC, 2009-2012), the Michael Smith Foundation for Health Research (MSFHR, 2006-7) and has served on the Boards of CPAC, MSFHR and Genome BC. He is an Adjunct Clinical Professor at the University of British Columbia and an Associate Scientist with the Michael Smith Genome Sciences Centre at the BC Cancer Agency.

Dr. Sutcliffe was awarded the Queen Elizabeth 50th Jubilee Gold Medal in 2003, and the Terry Fox Award of the BC Medical Association in 2009 for his lifetime services to cancer control.

DON DURAND

Don Durand joined Premier's board as of June 2, 2014. Mr. Durand is the President of Viewscape Management Consulting Inc., a company which provides management consultant services in several industry areas, including oil & gas, engineering services and high technology. Mr. Durand has extensive international experience serving as a director on several boards and has acted in various officer positions. His appointments include serving as President from November 2007 to present, of Buchanan Renewables Fuel Group (Liberia), a company specializing in wood biomass exportation using agri-waste, and serving as President and COO of the Transnational Automotive Group (Cameroon). Mr. Durand has served as a Captain (Combat Engineering) in the Canadian Armed Forces. In addition to his management consulting business, he is also presently the Executive in Residence at the Beedie School of Business at Simon Fraser University.

SANJEEV PARSAD

Sanjeev Parsad joined Premier's board on March 31, 2014. He is the founder and president of Corner Market Capital Corporation, a private equity firm that manages private investment funds in Canada and the USA, and he is the founder and owner of "The Corner of Berkshire & Fairfax" investor online forum, with over 1,900 members. Mr. Parsad is the National Director of the non-profit organization Dakshana Canada. Mr. Parsad was profiled in a chapter of Andrew Kilpatrick's book "Of Permanent Value," an anthology on Warren Buffett and Berkshire Hathaway, as well as John Mihaljevic's "The Manual of Ideas."

Mr. Parsad, through Corner Market Capital Corporation, recently provided the Company with the funds necessary to upgrade and expand the Company's Vancouver PET / CT Clinic.

Denis Tusar, the Company's President, CEO and a director, commented as follows: "We are very pleased to have such distinguished medical and business executives join our Board of Directors. Their confidence in joining our board is a great endorsement of our business plan and the Company's future."

Premier's New Officers are:

Grace Xian was appointed the Company's Chief Financial Officer and Marta Davidson was appointed Corporate Secretary as of May 21, 2014. Ms. Xian replaces Daniel Waters, Acting CFO and Ms. Davidson was appointed to replace Ian Robertson. Mr. Robertson remains a director of the Company and has been appointed Non Executive Chairman of the Company as of May 21, 2014. Mr. Waters remains with the Company in a new role as Accounting Manager and Investor Relations & Regulatory Affairs officer.

GRACE XIAN

Grace Xian received an Engineering degree with a focus on Management Information Systems from the prestigious Tsinghua University, China in 1993. She also received an MBA from Tsinghua University's School of Economics and Management in 2003. Ms. Xian has engineering and contract management experience in Canada and China, having worked as a project manager in the construction of power stations. Ms. Xian also has extensive enterprise management experience working in positions such deputy general manager and vice president of a US subsidiary of a major Chinese corporation and deputy general manager of human resources of the Chinese parent company. Ms. Xian originally joined Premier Diagnostic Health Services in May 2013 as the senior manager for International Affairs and Development.

MARTA DAVIDSON

Marta Davidson is a Vancouver‐based lawyer whose practice focuses on corporate finance and securities and communications law. Ms. Davidson holds a Bachelor of Laws degree from Bond University, Australia and a Master of Laws degree from the University of British Columbia.

About Premier Diagnostic Health Services Inc. ("PDHS")

PDHS is a Canadian company that provides, through its subsidiaries, advanced medical diagnostic tools using PET/CT technology and/or MRI technology and related diagnostic skills in Canada and in the People's Republic of China, in partnership with local medical professionals, public and private investors, hospitals and clinics. The Company's mission is to provide physicians and other health care professional with exceptional diagnostic information that will assist them in making medical decisions that lead to better outcomes for their patients. The Company's approach involves building long-term relationships regarding management, quality, and financial services that are necessary to build, operate and grow the diagnostic capacity and capability of hospitals and clinics worldwide.

On behalf of the Board of Directors

Denis Tusar, President and CEO

The Canadian Stock Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at www.sedar.com.